Abstract
Backgound/Aims Overt and subclinical hypothyroidism are reported to be associated with increased cardiovascular disease risk. We have used coronary flow reserve (CFR) measurement by trans-thoracic Doppler echocardiography (TTDE) to determine coronary microvascular function in Hashimoto’s thyroiditis patients with overt and subclinical hypothyroidism and to evaluate effects of l-thyroxine replacement on coronary endothelial function. Methods In total, 10 overt hypothyroid patients, 10 subclinical hypothyroid patients, and 10 controls were enrolled. FT4, TSH, anti-thyroid antibodies, lipid profile, insulin, glucose, HOMA-IR, physical parameters, and CFR measured by TTDE were recorded before and after 6 months of l-thyroxine replacement in all groups. Results CFR values of all hypothyroid patients at baseline were significantly lower than those in controls. After l-thyroxine, CFR increased significantly in overt and subclinical hypothyroidism with respect to the baseline measurements (P < 0.05). When baseline and second measurements were evaluated collectively for patients and controls, CFR was positively correlated with FT4 levels (r = 0.31, P = 0.01) and negatively correlated with TSH and HOMA-IR (r = −0.38, P = 0.002 and r = −0.42, P < 0.001, respectively). Conclusion Subclinical as well as overt hypothyroid patients have impaired coronary microvascular function which improved after l-thyroxine therapy. Treatment of Hashimoto’s thyroiditis patients with subclinical hypothyroidism should be considered to improve cardiovascular disease risk.
Similar content being viewed by others
References
A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Ann. Intern. Med. 132, 270–278 (2000)
G.J. Kahaly, Thyroid 10, 665–679 (2000)
G.D. Xiang, Y.S. He, L.S. Zhao, J. Hou, L. Yue, H.J. Xiang, Clin. Endocrinol. 64, 698–702 (2006)
A.W. Kung, R.W. Pang, E.D. Janus, Clin. Endocrinol. 43, 445–449 (1995)
W.I. Hussein, R. Green, D.W. Jacobsen, C. Faiman, Ann. Intern. Med. 131, 348–351 (1999)
B. Muller, D.A. Tsakiris, C.B. Roth, M. Guglielmetti, J.J. Staub, G.A. Marbet, Eur. J. Clin. Invest. 31, 131–137 (2001)
M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Sawin, N.F. Col, R.H. Cobin, J.A. Franklyn, J.M. Hershman, K.D. Burman, M.A. Denke, C. Gorman, R.S. Cooper, N.J. Weissman, JAMA 291, 228–238 (2004)
R.F. Furchgott, J.V. Zawadzki, Nature 288, 373–376 (1980)
R. Ross, N. Engl. J. Med. 314, 488–500 (1986)
A.H. Henderson, Br. Heart. J. 65, 116–125 (1991)
P.O. Bonetti, L.O. Lerman, A. Lerman, Arterioscler. Thromb. Vasc. Biol. 23, 168–175 (2003)
M.J. Jarvisalo, M. Juonala, O.T. Raitakari, Curr. Opin. Clin. Nutr. Metab. Care 9, 547–552 (2006)
B. Erzen, M. Sabovic, M. Sebestjen, I. Keber, P. Poredos, Cardiology 107, 111–116 (2006)
A.T. With Noto, E. Bogeberg Mathiesen, J. Amiral, A.M. Vissac, J.B. Hansen, Thromb. Haemost. 96, 53–59 (2006)
B.J. Wells, W.J. Hueston, Clin. Endocrinol. 62, 580–584 (2005)
S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, A. Salvetti, E. Ferrannini, F. Monzani, J. Clin. Endocrinol. Metab. 88, 3731–3737 (2003)
G.I. Papaioannou, M. Lagasse, J.F. Mather, P.D. Thompson, Metabolism 53, 278–279 (2004)
F. Rigo, Cardiovasc. Ultrasound 3, 8 (2005)
M. Galderisi, B. Capaldo, M. Sidiropulos, A. D’Errico, L. Ferrara, A. Turco, P. Guarini, G. Riccardi, O. de Divitiis, Am. J. Hypertens. 20, 1283–1290 (2007)
Y. Kataoka, S. Nakatani, N. Tanaka, H. Kanzaki, S. Yasuda, I. Morii, A. Kawamura, S. Miyazaki, M. Kitakaze, Circ. J. 71, 891–896 (2007)
S. Shimada, K. Harada, M. Toyono, M. Tamura, G. Takada, Circ. J. 71, 1912–1917 (2007)
K.L. Gould, K. Lipscomb, Am. J. Cardiol. 34, 48–55 (1974)
M.B. Britten, A.M. Zeiher, V. Schachinger, Coron. Artery Dis. 1585, 259–264 (2004)
A.C. Rodrigues, C.C. Frimm, F. Bacal, V. Andreolli, J.M. Tsutsui, E.A. Bocchi, W. Mathias Jr., S.G. Lage, Int. J. Cardiol. 103, 201–206 (2005)
H. Oflaz, R. Kurt, A. Cimen, A. Elitok, I. Onur, E. Golcuk, M. Demirturk, S. Batmaz, E. Kasikcioglu, Int. J. Cardiol. 120, 414–416 (2006)
D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Diabetologia 28, 412–419 (1985)
E. Kasikcioglu, A. Elitok, I. Onur, A. Cimen, A. Ucar, H. Oflaz, Int. J. Cardiol. Aug 24; [Epub ahead of print] (2007)
H. Oflaz, F. Sen, A. Elitok, A.O. Cimen, I. Onur, E. Kasikcioglu, S. Korkmaz, M. Demirturk, F. Kutluturk, B. Pamukcu, N. Ozbey, Clin. Endocrinol. 66, 524–529 (2007)
T. Hozumi, K. Yoshida, Y. Ogata, T. Akasaka, Y. Asami, T. Takagi, S. Morioka, Circulation 97, 1557–1562 (1998)
M. Yazici, S. Gorgulu, Y. Sertbas, E. Erbilen, S. Albayrak, O. Yildiz, C. Uyan, Int. J. Cardiol. 95, 135–143 (2004)
M.I. Surks, E. Ocampo, Am. J. Med. 100, 217–223 (1996)
A. Dardano, L. Ghiadoni, Y. Plantinga, N. Caraccio, A. Bemi, E. Duranti, S. Taddei, E. Ferrannini, A. Salvetti, F. Monzani, J. Clin. Endocrinol. Metab. 91, 4175–4178 (2006)
H. Masaki, M. Nishikawa, M. Urakami, M. Yoshimura, N. Toyoda, Y. Mori, N. Yoshikawa, M. Inada, J. Clin. Endocrinol. Metab. 75, 721–725 (1992)
R. Chadarevian, E. Bruckert, A. Ankri, I. Beucler, P. Giral, G. Turpin, Thromb. Haemost. 79, 99–103 (1998)
M. Owecki, E. Nikisch, J. Sowinski, Acta. Clin. Belg. 61, 69–73 (2006)
P.H. Dessein, B.I. Joffe, A.E. Stanwix, Thyroid 14, 443–446 (2004)
A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, J. Clin. Endocrinol. Metab. 92, 491–496 (2007)
O. Serri, P. St-Jacques, M. Sartippour, G. Renier, J. Clin. Endocrinol. Metab. 84, 58–63 (1999)
S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, E. Ferrannini, A. Savletti, F. Monzani, J. Clin. Endocrinol. Metab. 91, 5076–5082 (2006)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oflaz, H., Kurt, R., Sen, F. et al. Coronary flow reserve after l-thyroxine therapy in Hashimoto’s thyroiditis patients with subclinical and overt hypothyroidism. Endocr 32, 264–270 (2007). https://doi.org/10.1007/s12020-008-9037-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-008-9037-2